| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| V P Barkhatova, E G Larskiĭ, I A Ivanova-Smolenskaia, E D Markova, E G Demin. [Pathological status of catecholamines in the corpus striatum in hepatocerebral dystrophy (Wilson-Konovalov disease)]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). vol 92. issue 4. 1993-01-07. PMID:1333712. |
in view of this fact it is assumed that disorders of cerebral metabolism of catecholamines, dopamine in particular, evidently related to deposition of excess copper, leading to the changes of their content in basal ganglia underline the clinical pleomorphism of the disease and play the key role in the development of extrapyramidal motor disturbances characteristic of hepatocerebral dystrophy. |
1993-01-07 |
2023-08-11 |
Not clear |
| D T Blair, A Daune. Extrapyramidal symptoms are serious side-effects of antipsychotic and other drugs. The Nurse practitioner. vol 17. issue 11. 1992-12-23. PMID:1359485. |
extrapyramidal symptoms are caused by dopamine blockade or depletion in the basal ganglia; this lack of dopamine often mimics idiopathic pathologies of the extrapyramidal system. |
1992-12-23 |
2023-08-11 |
Not clear |
| G Chinaglia, F J Alvarez, A Probst, J M Palacio. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Neuroscience. vol 49. issue 2. 1992-12-14. PMID:1436470. |
in schizophrenic patients the density of dopamine uptake sites in the basal ganglia was slightly reduced, mainly in the middle third of putamen. |
1992-12-14 |
2023-08-11 |
Not clear |
| C A Vacanti, B S Silbert, F X Vacant. Fentanyl-induced muscle rigidity as affected by pretreatment with amantadine hydrochloride. Journal of clinical anesthesia. vol 4. issue 4. 1992-12-07. PMID:1419008. |
to determine whether the degree of muscle rigidity in humans caused by the administration of high-dose fentanyl is affected by pretreatment with amantadine hydrochloride, a drug that stimulates the release of dopamine in the basal ganglia. |
1992-12-07 |
2023-08-11 |
Not clear |
| Y Mano, T Nakamuro, K Ikoma, T Sugata, S Morimoto, T Takayanagi, R F Maye. Central motor conductivity in aged people. Internal medicine (Tokyo, Japan). vol 31. issue 9. 1992-12-04. PMID:1421713. |
aged people generally have an anteflexed posture, slow movements, and poor postural reflexes, and have been reported to have a decrease in the dopamine level which is relatively earlier than that of other transmitters in the basal ganglia. |
1992-12-04 |
2023-08-11 |
human |
| S Berretta, H A Robertson, A M Graybie. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. Journal of neurophysiology. vol 68. issue 3. 1992-11-27. PMID:1359024. |
the monoamine dopamine and the amino acid glutamate are major neurotransmitters in the basal ganglia implicated in the normal functions of the striatum and in extrapyramidal disease states. |
1992-11-27 |
2023-08-11 |
rat |
| H A Ring, M R Trimble, D C Costa, M S George, P Verhoeff, P J El. Effect of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems. Journal of neurology, neurosurgery, and psychiatry. vol 55. issue 9. 1992-11-10. PMID:1328538. |
using 123i-ibzm, a specific dopamine d2 receptor ligand and single photon emission tomography (spet), one month of treatment with vigabatrin was associated with a decrease in specific binding of 123i-ibzm to d2 receptors in the left hemisphere basal ganglia. |
1992-11-10 |
2023-08-11 |
Not clear |
| H Saji, Y Iida, Y Magata, Y Yonekura, Y Iwasaki, S Sasayama, J Konishi, I Nakatsuka, K Shiba, A Yoshitak. Preparation of 123I-labeled 2'-iodospiperone and imaging of D2 dopamine receptors in the human brain using SPECT. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. vol 19. issue 5. 1992-10-26. PMID:1399682. |
a preliminary imaging study with [123i]2'-isp in a healthy human volunteer showed its specific uptake by the basal ganglia, a region of the brain known to have a high density of d2 dopamine receptors. |
1992-10-26 |
2023-08-11 |
mouse |
| G Sedval. The current status of PET scanning with respect to schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 7. issue 1. 1992-10-16. PMID:1388021. |
pet measurements of dopamine receptor functions in the major basal ganglia using different radioligands for d2 dopamine receptors also gave inconsistent results. |
1992-10-16 |
2023-08-11 |
human |
| A Lazaru. Neuroleptic malignant syndrome and preexisting brain damage. The Journal of neuropsychiatry and clinical neurosciences. vol 4. issue 2. 1992-08-18. PMID:1627980. |
the literature suggests that nms in patients with organic brain syndrome is induced by a reduction of marginal stores of dopamine in the hypothalamus and basal ganglia resulting from dopamine-blocking activity of neuroleptics, even at conventionally low doses. |
1992-08-18 |
2023-08-11 |
Not clear |
| G Sedvall, L Farde, H Nybäck, S Pauli, A Persson, I Savic, F A Wiese. Recent advances in psychiatric brain imaging. Acta radiologica. Supplementum. vol 374. 1992-07-17. PMID:1966956. |
no alteration of d2 dopamine receptors in the major basal ganglia were found in drug naive schizophrenic patients. |
1992-07-17 |
2023-08-11 |
human |
| K D Anderson, A Reine. Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons. Brain research. vol 568. issue 1-2. 1992-06-23. PMID:1839966. |
immunohistochemical double-label techniques were used to study the localization of darpp-32, a phosphoprotein that is enriched in neurons possessing members of the d1 subfamily of dopamine receptors, in several different types of striatal neurons in the rat basal ganglia. |
1992-06-23 |
2023-08-11 |
rat |
| G E Jaskiw, D R Weinberge. Ibotenic acid lesions of medial prefrontal cortex augment swim-stress-induced locomotion. Pharmacology, biochemistry, and behavior. vol 41. issue 3. 1992-06-18. PMID:1584841. |
dysregulation of dopamine transmission in the basal ganglia may be involved. |
1992-06-18 |
2023-08-11 |
rat |
| A Biegon, K Dillon, N D Volkow, R J Hitzemann, J S Fowler, A P Wol. Quantitative autoradiography of cocaine binding sites in human brain postmortem. Synapse (New York, N.Y.). vol 10. issue 2. 1992-06-18. PMID:1585256. |
preliminary competition experiments with several drugs indicate that dopamine uptake inhibitors completely block cocaine binding to the basal ganglia, while serotonin uptake inhibitors were more effective in the hippocampus. |
1992-06-18 |
2023-08-11 |
human |
| A Biegon, K Dillon, N D Volkow, R J Hitzemann, J S Fowler, A P Wol. Quantitative autoradiography of cocaine binding sites in human brain postmortem. Synapse (New York, N.Y.). vol 10. issue 2. 1992-06-18. PMID:1585256. |
these findings suggest that cocaine binds to dopamine uptake sites in the human basal ganglia postmortem but that it also interacts with other classes of binding sites, depending on the concentration and brain region examined. |
1992-06-18 |
2023-08-11 |
human |
| L Farde, H Hal. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands. Arzneimittel-Forschung. vol 42. issue 2A. 1992-06-16. PMID:1316756. |
in conclusion, these ligands can be used to quantitatively examine dopamine receptors in the human basal ganglia in vivo. |
1992-06-16 |
2023-08-11 |
human |
| J Schwarz, K Tatsch, T Vogl, C M Kirsch, C Trenkwalder, G Arnold, T Gasser, W H Oerte. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia. Movement disorders : official journal of the Movement Disorder Society. vol 7. issue 1. 1992-05-04. PMID:1532631. |
ibzm is a dopamine d2 receptor antagonist with high affinity and specific binding to basal ganglia detectable by spect. |
1992-05-04 |
2023-08-11 |
Not clear |
| L W Toled. The postanesthesia patient with Parkinson's disease. Journal of post anesthesia nursing. vol 7. issue 1. 1992-03-12. PMID:1531238. |
concentrations of dopamine and acetylcholine, neurotransmitters in the substantia nigra of the basal ganglia, become imbalanced. |
1992-03-12 |
2023-08-11 |
Not clear |
| M S Aldrich, Z Hollingsworth, J B Penne. Dopamine-receptor autoradiography of human narcoleptic brain. Neurology. vol 42. issue 2. 1992-03-12. PMID:1736175. |
we used quantitative autoradiography to assess dopamine d1- and d2-receptor binding in basal ganglia and amygdala of five narcoleptic and 17 control human brains. |
1992-03-12 |
2023-08-11 |
human |
| J Logan, S L Dewey, A P Wolf, J S Fowler, J D Brodie, B Angrist, N D Volkow, S J Gatle. Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboons. Synapse (New York, N.Y.). vol 9. issue 3. 1992-03-05. PMID:1685599. |
effects of endogenous dopamine on measures of [18f]n-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from pet studies in baboons. |
1992-03-05 |
2023-08-11 |
human |